Registro:

Referencias:

• Carbia-Nagashima, A., Gerez, J., Perez-Castro, C., Paez-Pereda, M., Silberstein, S., Stalla, G.K., Holsboer, F., Arzt, E., RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia (2007) Cell, 131, pp. 309-323
• Castro, C.P., Giacomini, D., Nagashima, A.C., Onofri, C., Graciarena, M., Kobayashi, K., Paez- Pereda, M., Arzt, E., Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells (2003) Endocrinology, 144, pp. 693-700
• Gerez, J., Fuertes, M., Tedesco, L., Silberstein, S., Sevlever, G., Paez-Pereda, M., Holsboer, F., Arzt, E., In silico structural and functional characterization of the RSUME splice variants (2013) PLoS ONE, 8, p. e57795
• https://genome.ucsc.edu/Genome, Browser; Rojewska, E., Korostynski, M., Przewlocki, R., Przewlocka, B., Mika, J., Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain (2014) Mol. Pain, 10, p. 47
• Willi-Monnerat, S., Migliavacca, E., Surdez, D., Delorenzi, M., Luthi-Carter, R., Terskikh, A.V., Comprehensive spatiotemporal transcriptomic analyses of the ganglionic eminences demonstrate the uniqueness of its caudal subdivision (2008) Mol. Cell. Neurosci., 37, pp. 845-856
• Druker, J., Liberman, A.C., Antunica-Noguerol, M., Gerez, J., Paez-Pereda, M., Rein, T., Iniguez- Lluhi, J.A., Arzt, E., RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity (2013) Mol. Cell. Biol., 33, pp. 2116-2127
• Shan, B., Gerez, J., Haedo, M., Fuertes, M., Theodoropoulou, M., Buchfelder, M., Losa, M., Renner, U., RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells (2012) Endocr. Relat. Cancer, 19, pp. 13-27
• Gerez, J., Tedesco, L., Bonfiglio, J.J., Fuertes, M., Barontini, M., Silberstein, S., Wu, Y., Arzt, E., RSUME inhibits VHL and regulates its tumor suppressor function (2014) Oncogene
• Gill, G., SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms? (2004) Genes Dev., 18, pp. 2046-2059
• Hay, R.T., SUMO: A history of modification (2005) Mol. Cell, 18, pp. 1-12
• Johnson, E.S., Protein modification by SUMO (2004) Annu. Rev. Biochem., 73, pp. 355-382
• Ciechanover, A., The ubiquitin-proteasome proteolytic pathway (1994) Cell, 79, pp. 13-21
• Hochstrasser, M., Origin and function of ubiquitin-like proteins (2009) Nature, 458, pp. 422-429
• Vertegaal, A.C., Ogg, S.C., Jaffray, E., Rodriguez, M.S., Hay, R.T., Andersen, J.S., Mann, M., Lamond, A.I., A proteomic study of SUMO-2 target proteins (2004) J. Biol. Chem., 279, pp. 33791-33798
• Melchior, F., SUMO - Nonclassical ubiquitin (2000) Annu. Rev. Cell Dev. Biol., 16, pp. 591-626
• Melchior, F., Schergaut, M., Pichler, A., SUMO: Ligases, isopeptidases and nuclear pores (2003) Trends Biochem. Sci., 28, pp. 612-618
• Alontaga, A.Y., Ambaye, N.D., Li, Y.J., Vega, R., Chen, C.H., Bzymek, K.P., Williams, J.C., Chen, Y., RWD domain as an E2 (Ubc9)-interaction module (2015) J. Biol. Chem., 290, pp. 16550-16559
• Gordan, J.D., Simon, M.C., Hypoxia-inducible factors: Central regulators of the tumor phenotype (2007) Curr. Opin. Genet. Dev., 17, pp. 71-77
• Semenza, G.L., HIF-1 mediates the Warburg effect in clear cell renal carcinoma (2007) J. Bioenerg. Biomembr., 39, pp. 231-234
• Brahimi-Horn, M.C., Pouyssegur, J., HIF at a glance (2009) J. Cell Sci., 122, pp. 1055-1057
• Semenza, G.L., Hypoxia-inducible factor 1: Master regulator of O2 homeostasis (1998) Curr. Opin. Genet. Dev., 8, pp. 588-594
• Ke, Q., Costa, M., Hypoxia-inducible factor-1 (HIF-1) (2006) Mol. Pharmacol., 70, pp. 1469-1480
• Huang, C.C., Tu, S.H., Lien, H.H., Jeng, J.Y., Huang, C.S., Huang, C.J., Lai, L.C., Chuang, E.Y., Concurrent gene signatures for Han Chinese breast cancers (2013) PLoS ONE, 8, p. e76421
• Schneider, B.P., Li, L., Miller, K., Flockhart, D., Radovich, M., Hancock, B.A., Kassem, N., Sledge, G.W., Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103 (2011) J. Clin. Oncol., p. 29
• Arzt, E., Pereda, M.P., Castro, C.P., Pagotto, U., Renner, U., Stalla, G.K., Pathophysiological role of the cytokine network in the anterior pituitary gland (1999) Front. Neuroendocrinol., 20, pp. 71-95
• Asa, S.L., Ezzat, S., The pathogenesis of pituitary tumours (2002) Nat. Rev. Cancer, 2, pp. 836-849
• Ezzat, S., Asa, S.L., Couldwell, W.T., Barr, C.E., Dodge, W.E., Vance, M.L., McCutcheon, I.E., The prevalence of pituitary adenomas: A systematic review (2004) Cancer, 101, pp. 613-619
• Melmed, S., Pathogenesis of pituitary tumors (2011) Nat. Rev. Endocrinol., 7, pp. 257-266
• De La Torre, N.G., Turner, H.E., Wass, J.A., Angiogenesis in prolactinomas: Regulation and relationship with tumour behaviour (2005) Pituitary, 8, pp. 17-23
• Turner, H.E., Harris, A.L., Melmed, S., Wass, J.A., Angiogenesis in endocrine tumors (2003) Endocr. Rev., 24, pp. 600-632
• Ferrara, N., Vascular endothelial growth factor: Basic science and clinical progress (2004) Endocr. Rev., 25, pp. 581-611
• Carmeliet, P., Angiogenesis in health and disease (2003) Nat. Med., 9, pp. 653-660
• Kirsch, M., Wilson, J.C., Black, P., Platelet-derived growth factor in human brain tumors (1997) J. Neurooncol., 35, pp. 289-301
• Cristina, C., Perez-Millan, M.I., Luque, G., Dulce, R.A., Sevlever, G., Berner, S.I., Becu- Villalobos, D., VEGF and CD31 association in pituitary adenomas (2010) Endocr. Pathol., 21, pp. 154-160
• He, W., Shen, X., Wang, D., Fan, Y., Zhang, Y., Tu, W., Zhu, X., Relationship of RSUME and HIF-1α/VEGF pathways with invasion of pituitary adenoma (2015) Tumor, 35, pp. 423-430
• Fowkes, R.C., Vlotides, G., Hypoxia-induced VEGF production 'RSUMEs' in pituitary adenomas (2012) Endocr. Relat. Cancer, 19, pp. C1-C5
• Gupta, K., Salunke, P., Molecular markers of glioma: An update on recent progress and perspectives (2012) J. Cancer Res. Clin. Oncol., 138, pp. 1971-1981
• Verhaak, R.G., Hoadley, K.A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M.D., Miller, C.R., Hayes, D.N., Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 (2010) Cancer Cell, 17, pp. 98-110
• Morokoff, A., Ng, W., Gogos, A., Kaye, A., Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma (2015) J. Clin. Neurosci.
• Mizukami, Y., Jo, W.S., Duerr, E.M., Gala, M., Li, J., Zhang, X., Zimmer, M.A., Chung, D.C., Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells (2005) Nat. Med., 11, pp. 992-997
• Maher, E.R., Neumann, H.P., Richard, S., Von Hippel-Lindau disease: A clinical and scientific review (2011) Eur. J. Hum. Genet., 19, pp. 617-623
• Kim, W.Y., Kaelin, W.G., Role of VHL gene mutation in human cancer (2004) J. Clin. Oncol., 22, pp. 4991-5004
• Hussein, M.R., Central nervous system capillary haemangioblastoma: The pathologist's viewpoint (2007) Int. J. Exp. Pathol., 88, pp. 311-324
• Knauth, K., Bex, C., Jemth, P., Buchberger, A., Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions (2006) Oncogene, 25, pp. 370-377
• Rathmell, W.K., Hickey, M.M., Bezman, N.A., Chmielecki, C.A., Carraway, N.C., Simon, M.C., In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations (2004) Cancer Res., 64, pp. 8595-8603
• Pause, A., Lee, S., Worrell, R.A., Chen, D.Y., Burgess, W.H., Linehan, W.M., Klausner, R.D., The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins (1997) Proc. Natl. Acad. Sci. U.S.A., 94, pp. 2156-2161
• Lonergan, K.M., Iliopoulos, O., Ohh, M., Kamura, T., Conaway, R.C., Conaway, J.W., Kaelin, W.G., Jr., Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2 (1998) Mol. Cell. Biol., 18, pp. 732-741
• Kaelin, W.G., Proline hydroxylation and gene expression (2005) Annu. Rev. Biochem., 74, pp. 115-128
• Ohh, M., Park, C.W., Ivan, M., Hoffman, M.A., Kim, T.Y., Huang, L.E., Pavletich, N., Kaelin, W.G., Ubiquitination of hypoxia-inducible factor requires direct binding to the beta- domain of the von Hippel-Lindau protein (2000) Nat. Cell Biol., 2, pp. 423-427
• Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Schultz, N., The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data (2012) Cancer Discovery, 2, pp. 401-404
• Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Schultz, N., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal (2013) Sci. Signal., 6, p. 1
• Cancer Genome Atlas Research Network, Comprehensive molecular characterization of clear cell renal cell carcinoma (2013) Nature, 499, pp. 43-49
• Van Hagen, M., Overmeer, R.M., Abolvardi, S.S., Vertegaal, A.C., RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2alpha (2010) Nucleic Acids Res., 38, pp. 1922-1931
• Besedovsky, H.O., Del Rey, A., Immune-neuroendocrine circuits: Integrative role of cytokines (1992) Front. Neuroendocrinol., 13, pp. 61-94
• Druker, J., Liberman, A.C., Acuna, M., Giacomini, D., Refojo, D., Silberstein, S., Pereda, M.P., Arzt, E., Molecular understanding of cytokine-steroid hormone dialogue: Implications for human diseases (2006) Ann. N. Y. Acad. Sci., 1088, pp. 297-306
• Pereda, M.P., Lohrer, P., Kovalovsky, D., Perez Castro, C., Goldberg, V., Losa, M., Chervin, A., Arzt, E., Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas (2000) Exp. Clin. Endocrinol. Diabetes, 108, pp. 202-207
• De Bosscher, K., Vanden Berghe, W., Haegeman, G., The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: Molecular mechanisms for gene repression (2003) Endocr. Rev., 24, pp. 488-522
• Ashwell, J.D., Lu, F.W., Vacchio, M.S., Glucocorticoids in T cell development and function (2000) Annu. Rev. Immunol., 18, pp. 309-345
• Liberman, A.C., Druker, J., Perone, M.J., Arzt, E., Glucocorticoids in the regulation of transcription factors that control cytokine synthesis (2007) Cytokine Growth Factor Rev., 18, pp. 45-56
• Reichardt, H.M., Tuckermann, J.P., Gottlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., Schutz, G., Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor (2001) EMBO J., 20, pp. 7168-7173
• Caldenhoven, E., Liden, J., Wissink, S., Van De Stolpe, A., Raaijmakers, J., Koenderman, L., Okret, S., Van Der Saag, P.T., Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids (1995) Mol. Endocrinol., 9, pp. 401-412
• Stocklin, E., Wissler, M., Gouilleux, F., Groner, B., Functional interactions between Stat5 and the glucocorticoid receptor (1996) Nature, 383, pp. 726-728
• Scheinman, R.I., Cogswell, P.C., Lofquist, A.K., Baldwin, A.S., Jr., Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids (1995) Science, 270, pp. 283-286
• Desterro, J.M., Rodriguez, M.S., Hay, R.T., SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation (1998) Mol. Cell, 2, pp. 233-239
• Hay, R.T., Vuillard, L., Desterro, J.M., Rodriguez, M.S., Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha (1999) Philos. Trans. R. Soc. Lond. B Biol. Sci., 354, pp. 1601-1609
• Tian, S., Poukka, H., Palvimo, J.J., Janne, O.A., Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor (2002) Biochem. J., 367, pp. 907-911
• Le Drean, Y., Mincheneau, N., Le Goff, P., Michel, D., Potentiation of glucocorticoid receptor transcriptional activity by sumoylation (2002) Endocrinology, 143, pp. 3482-3489

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------